NASDAQ:GYRE | ROE | GYRE THERAPEUTICS, INC.

Complete source-backed roe history.

Available history
2009-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-30-26.16%
2026-03-31-15.99%
2025-12-3111.71%
2025-09-309.06%
2025-06-306.69%
2025-03-3118.98%
2024-12-3128.31%
2024-09-30-101.87%
2024-06-30-98.94%
2024-03-31-106.77%
2023-12-31418.21%
2023-09-30-352.60%
2023-06-3087.57%
2023-03-31-88.88%
2022-12-3110.15%
2022-09-3040.45%
2022-06-30-10.71%
2022-03-31-295.49%
2021-12-31-214.01%
2021-09-30-142.44%
2021-06-30-90.77%
2021-03-31-71.69%
2020-12-31-73.93%
2020-09-30-54.16%
2020-06-30-43.70%
2020-03-31-45.27%
2019-12-31-80.75%
2019-09-30-64.48%
2019-06-30-50.90%
2019-03-31-37.89%
2018-12-31-25.06%
2018-09-30-19.22%
2018-06-30-16.84%
2018-03-31-15.73%
2017-12-31-70.06%
2017-09-30-78.60%
2017-06-30-61.08%
2017-03-31-126.42%
2016-12-31-105.44%
2016-09-30-93.48%
2016-06-30-79.24%
2016-03-31-55.37%
2015-12-31-46.98%
2015-09-30-30.20%
2015-06-30-7.42%
2015-03-31-13.37%
2014-12-3123.72%
2014-09-30-1.12%
2014-06-30-10.82%
2014-03-31-13.62%
2013-12-319.67%
2013-09-30-33.54%
2013-06-30-27.93%
2013-03-31-10.22%
2012-12-317.50%
2012-09-30-0.49%
2012-06-30-1.07%
2012-03-31-10.55%
2011-12-31-4.89%
2011-09-30-0.49%
2011-06-305.63%

Annual ROE

DateROE
2025-12-319.32%
2024-12-3128.27%
2023-12-31540.06%
2022-12-3110.15%
2021-12-31-214.01%
2020-12-31-73.93%
2019-12-31-80.75%
2018-12-31-25.06%
2017-12-31-70.06%
2016-12-31-105.44%
2015-12-31-46.98%
2014-12-316.05%
2013-12-319.67%
2012-12-317.50%
2011-12-31-4.89%
2010-12-3111.87%
2009-12-31-57.11%